2021.05.26 Press release

--To the press -

FRONTEO AI Innovation Forum 2021 held

A hybrid conference of online / offline with the theme of "intelligence to know the present and the future"

FRONTEO Inc.
Masahiro Morimoto, President and CEO
東京 都 港区 港 南 2-12-23
(Code number: 2158 TSE Mothers)

FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereinafter FRONTEO) will hold "FRONTEO AI Innovation Forum 2021" at Tokyo Conference Center Shinagawa on Wednesday, July 7, 7. I will.

 

FRONTEO AI Innovation Forum 2021 is the third private conference sponsored by FRONTEO this year, with the theme of "intelligence to know the present and the future."At each of the past two conferences, we have introduced the current status and results of FRONTEO's AI utilization in companies. This time, which is the third time, more than 3 lectures on drug discovery, skill transfer, compliance, etc. will be given on how FRONTEO's language analysis AI, which is widely used in Japan and overseas, can contribute to the decision making that will shape the future of the company. We will introduce it through exhibitions.You can experience the latest trends in AI utilization with more content than usual, so please join us.

 

At this conference, we will give a keynote speech by Shusaku Tsumoto, a professor of Shimane University School of Medicine, as well as various lectures on the theme of our latest initiatives, customer cases, and technological trends.

 

 

【Webinar Summary】

Event Dates

July 2021, 7 (Wednesday) 7: 11-00: 17 (00:10 opening / reception start)

Held format

Online, offline

How to book?

Pre-registration system (free)

https://www.fronteo-ai-forum.com/

 

[Main speakers]* The order may change.

Keynote speech

  IEEE SMC TC on Granular Computing Chair

  Shimane University School of Medicine Professor Shusaku Tsumoto

 

Invited lecture

  Professor, Research Center for Advanced Science and Technology, University of Tokyo 
  Professor Katsuya Tamai, Faculty of Economics, Shinshu University

  <Interview>

  Katsuya Tamai, Professor, Research Center for Advanced Science and Technology, University of Tokyo

  Masahiro Morimoto, President and CEO of FRONTEO Inc.

 

Lecture

<Legal Tech (Interview)>

 Mr. Takenao Sasaki, General Manager, Legal Department, Taiyo Yuden Co., Ltd.

 Mori Hamada & Matsumoto Law Office Partner Attorney Kenji Ito

 

<Life science>

  1. Mr. Kazuya Okawa, General Manager, Clinical Division, CMIC Co., Ltd.
  2. Mr. Takashi Ogawa, Co-Founder and CEO of MOLCURE Co., Ltd.

 

<Business Intelligence>

  1. Tokio Marine & Nichido Fire Insurance Co., Ltd. CX Process Design Department
    Customer Voice Room Mr. Takumi Ike, Manager, Planning Group, Business Quality Department
  2. Mr. Kenichi Baba, General Manager, Production Engineering Department, Showa Denko KK
  3. Mr. Kentaro Tokura, General Manager, Digital Construction Promotion Department, Technology Division, Sumitomo Mitsui Construction Co., Ltd.

 

Closing keynote

 Yukio Osawa, Professor, Department of Systems Innovation, Graduate School of Engineering, The University of Tokyo

 

 

 

FRONTEO  URL: https://www.fronteo.com/

FRONTEO uses the in-house developed AI engine "KIBIT" and "concept encoder" specializing in natural language processing to extract meaningful and important information from a huge amount of text data to support corporate business. A data analysis company. Since its establishment in August 2003, it has been expanding globally to Japan, the United States, South Korea, and Taiwan, focusing on legal tech businesses such as "e-discovery (electronic discovery)" and "digital forensic investigation" that support international litigation of companies. Has been deployed.Based on the AI ​​technology cultivated in the legal tech business, we expanded the business field to the life science field, business intelligence field, and OSINT from 8, and created by using AI to "turn text data into knowledge". We contribute to solving various corporate issues such as drug support, dementia diagnosis support, financial, human resources, and sales support. Listed on TSE Mothers on June 2014, 2007. January 6, 26 Obtained a first-class medical device manufacturing and sales license (permit number: 2021B1X13).The capital is 13 thousand yen (as of March 1, 10350).

 

* FRONTEO, KIBIT, and concept encoder are registered trademarks of FRONTEO in Japan.

<Contact information for the press>

Public Relations Officer, FRONTEO Inc. Takigawa

E-mail: pr_contact@fronteo.com

ja 日本語
Machine Translation by Google. : close x